lysophosphatidic acid has been researched along with Atherogenesis in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 20 (90.91) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Chattopadhyay, A; Fogelman, AM; Reddy, ST | 1 |
| Kamato, D; Little, PJ; Ta, HT; Xu, S; Zhou, Y | 1 |
| Chen, L; Deng, X; Liu, Y; Yang, X; Yu, C; Zhang, J | 1 |
| Guo, T; Li, F; Shen, X; Zhang, T; Zou, J | 1 |
| Angel, PM; Drake, RR; Fang, XF; Kraemer, M; Morris, AJ; Smyth, SS; Yang, L | 1 |
| Akamine, T; Ishizawa, S; Kanazawa, Y; Kawanami, D; Matoba, K; Nagai, Y; Takeda, Y; Utsunomiya, K; Yokota, T | 1 |
| Brandon, JA; Morris, AJ; Mueller, P; Smyth, SS; Yang, F | 1 |
| Bao, S; Day, R; Tan, C; Turk, J; Zhao, QD | 1 |
| Getz, GS; Reardon, CA | 1 |
| Anantharamaiah, GM; Chattopadhyay, A; Faull, KF; Fogelman, AM; Fogelman, SI; Grijalva, V; Hough, G; Hwang, LH; Meriwether, D; Navab, M; Reddy, ST; Su, F; Wagner, AC | 1 |
| Morris, A; Mueller, P; Smyth, SS; Ye, S | 1 |
| Abdel-Latif, A; Heron, PM; Morris, AJ; Smyth, SS | 1 |
| Bot, I; Kritikou, E; Kröner, MJ; Kuiper, J; Schaftenaar, FH; Swart, M; van der Heijden, T; van Puijvelde, GH; van Santbrink, PJ | 1 |
| Cong, YN; Li, ZG; Sun, HR; Wang, PF; Wu, QZ; Zhang, JB; Zhang, JS | 1 |
| Biessen, EA; Bot, I; Bot, M; David, S; Helms, JB; Lopez-Vales, R; Saulnier-Blache, JS; van Berkel, TJ; van de Lest, CH | 1 |
| Brandl, R; Khandoga, AL; Pandey, D; Siess, W; Welsch, U | 1 |
| Anantharamaiah, GM; Fogelman, AM; Hama, S; Hough, G; Imaizumi, S; Navab, M; Reddy, ST | 1 |
| Chun, J; Globke, B; Heyll, K; Karshovska, E; Megens, R; Reinholz, M; Saulnier-Blache, JS; Schober, A; Sevilmis, G; Soehnlein, O; Subramanian, P; van Zandvoort, M; Weber, C; Zhou, Z | 1 |
| Chai, H; Chen, C; Kagan, A; Liang, Z; Lin, PH; Ochoa, LN; Yao, Q | 1 |
| Schober, A; Siess, W | 1 |
| Anantharamaiah, GM; Chattopadhyay, A; Farias-Eisener, R; Farias-Eisner, R; Fogelman, AM; Gao, F; Grijalva, V; Hough, G; Meriwether, D; Namiri-Kalantari, R; Navab, M; Palgnachari, MN; Reddy, ST; Springstead, JR; Su, F; Van Lenten, BJ; Wagner, AC | 1 |
| Calay, D; Delaive, E; Dieu, M; Gustin, C; Raes, M | 1 |
7 review(s) available for lysophosphatidic acid and Atherogenesis
| Article | Year |
|---|---|
The multiple roles of lysophosphatidic acid in vascular disease and atherosclerosis.
Topics: Atherosclerosis; Endothelial Cells; Humans; Intestine, Small; Lysophospholipids | 2023 |
Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease.
Topics: Animals; Atherosclerosis; Humans; Lysophospholipids; Receptors, Lysophosphatidic Acid; Signal Transduction; Vascular Diseases | 2019 |
Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.
Topics: Adipose Tissue; Animals; Apolipoproteins E; Atherosclerosis; Coronary Artery Disease; Genetic Predisposition to Disease; Humans; Lysophospholipids; Mice; Mice, Knockout; Phosphatidate Phosphatase; Phosphoric Diester Hydrolases; Plaque, Atherosclerotic; Risk; Sphingosine | 2014 |
The structure/function of apoprotein A-I mimetic peptides: an update.
Topics: Anti-Inflammatory Agents; Antioxidants; Apolipoprotein A-I; Atherosclerosis; Biomimetic Materials; Diet; Female; Humans; Inflammation; Intestine, Small; Lysophospholipids; Male; Plants, Genetically Modified; Solanum lycopersicum; Structure-Activity Relationship | 2014 |
Lysophospholipid mediators in the vasculature.
Topics: Animals; Atherosclerosis; Blood Vessels; Cell Communication; Humans; Lysophospholipids; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction | 2015 |
Lysophospholipids in coronary artery and chronic ischemic heart disease.
Topics: Animals; Atherosclerosis; Coronary Artery Disease; Humans; Lysophospholipids; Myocardial Ischemia; Signal Transduction; Sphingosine | 2015 |
Lysophosphatidic acid in atherosclerotic diseases.
Topics: Animals; Atherosclerosis; Drug Design; Humans; Lysophospholipids; Signal Transduction; Thrombosis | 2012 |
15 other study(ies) available for lysophosphatidic acid and Atherogenesis
| Article | Year |
|---|---|
Lysophosphatidic acid decreased macrophage foam cell migration correlated with downregulation of fucosyltransferase 8 via HNF1α.
Topics: Animals; Atherosclerosis; Cell Movement; Disease Models, Animal; Down-Regulation; Foam Cells; Fucosyltransferases; HEK293 Cells; Hepatocyte Nuclear Factor 1-alpha; Humans; Lysophospholipids; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Protein Processing, Post-Translational; RAW 264.7 Cells; Receptors, Lysophosphatidic Acid; Signal Transduction | 2019 |
Lysophosphatidic acid enhances neointimal hyperplasia following vascular injury through modulating proliferation, autophagy, inflammation and oxidative stress.
Topics: Animals; Atherosclerosis; Cell Proliferation; Hyperplasia; Inflammation; Lysophospholipids; Male; Neointima; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2018 |
LPA receptor 4 deficiency attenuates experimental atherosclerosis.
Topics: Animals; Atherosclerosis; Cells, Cultured; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Purinergic | 2019 |
ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells.
Topics: Actin Cytoskeleton; Active Transport, Cell Nucleus; Aorta; Atherosclerosis; Cell Adhesion; Cell Movement; Chemokine CCL2; E-Selectin; Endothelial Cells; Gene Expression Regulation; Humans; I-kappa B Kinase; Lysophospholipids; Monocytes; Phosphorylation; rho-Associated Kinases; Signal Transduction; Transcription Factor RelA | 2019 |
Group VIA phospholipase A2 mediates enhanced macrophage migration in diabetes mellitus by increasing expression of nicotinamide adenine dinucleotide phosphate oxidase 4.
Topics: Animals; Atherosclerosis; Cell Movement; Cells, Cultured; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Group VI Phospholipases A2; Hydrogen Peroxide; Lysophospholipids; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 4; NADPH Oxidases; Oligonucleotides, Antisense; Receptors, LDL; Signal Transduction; Stress, Physiological; Time Factors; Transfection; Up-Regulation | 2014 |
Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.
Topics: Animals; Aorta; Atherosclerosis; Benzoxazoles; Dietary Fats; Dyslipidemias; Female; Group IB Phospholipases A2; Intestinal Absorption; Intestinal Mucosa; Intestines; Jejunum; Liver; Lysophosphatidylcholines; Lysophospholipids; Male; Mice; Phosphoric Diester Hydrolases; Piperazines; Receptors, LDL | 2015 |
Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice.
Topics: Animals; Atherosclerosis; Cholesterol, LDL; Disease Models, Animal; Endocytosis; Humans; Isoxazoles; Lysophospholipids; Mice; Propionates; Receptors, LDL; Receptors, Lysophosphatidic Acid; Signal Transduction | 2016 |
Plasma Phospholipids are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.
Topics: Aged; Aged, 80 and over; Ankle Brachial Index; Atherosclerosis; C-Reactive Protein; Carotid Intima-Media Thickness; Cognitive Dysfunction; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Lysophospholipids; Male; Middle Aged; Neuropsychological Tests; Phospholipids; Retrospective Studies | 2017 |
Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation.
Topics: Acyltransferases; Animals; Atherosclerosis; Carotid Arteries; Diet; Disease Progression; Gene Expression Profiling; Group VI Phospholipases A2; Homeostasis; Humans; Lysophospholipids; Male; Mice; Mice, Knockout; Molecular Sequence Data; Receptors, LDL | 2010 |
GPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques.
Topics: Atherosclerosis; Cell Line; Cell Shape; Humans; Lipid Metabolism; Lysophospholipids; Megakaryocytes; Microscopy, Electron, Scanning; Nephelometry and Turbidimetry; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA Interference; Time Factors; Transfection | 2011 |
Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.
Topics: Administration, Cutaneous; Administration, Oral; Amino Acid Sequence; Animals; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Feces; Female; Gene Deletion; Inflammation; Intestinal Mucosa; Lipoproteins, HDL; Liver; Lysophospholipids; Mice; Mice, Knockout; Molecular Mimicry; Molecular Sequence Data; Peptides; Serum Amyloid A Protein | 2011 |
Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Carotid Arteries; Cells, Cultured; Chemokine CXCL1; Diet, Atherogenic; Endothelium, Vascular; Hyperlipidemias; Lipoproteins, LDL; Lysophospholipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Receptors, Lysophosphatidic Acid; RNA, Small Interfering | 2011 |
Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.
Topics: Animals; Atherosclerosis; Bradykinin; Coronary Vessels; Down-Regulation; Endothelium, Vascular; Humans; Lysophospholipids; Membrane Potential, Mitochondrial; Nitric Oxide Synthase Type III; Oxidative Stress; Selenomethionine; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides; Swine; Vasodilation | 2012 |
A novel approach to oral apoA-I mimetic therapy.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Cholesterol; Female; Hydroxyeicosatetraenoic Acids; Intestine, Small; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptides; Plants, Genetically Modified; Receptors, LDL; Solanum lycopersicum; Triglycerides | 2013 |
Upregulation of pentraxin-3 in human endothelial cells after lysophosphatidic acid exposure.
Topics: Analysis of Variance; Atherosclerosis; C-Reactive Protein; Cells, Cultured; Endothelial Cells; Gene Expression Regulation; Humans; Immunoblotting; Lysophospholipids; Probability; Receptors, Lysophosphatidic Acid; RNA, Messenger; Sensitivity and Specificity; Serum Amyloid P-Component; Umbilical Veins; Up-Regulation | 2008 |